European Authorities recommended the first needle-free system for
acute postoperative pain for approval this week, which allows
patient-controlled delivery of fentanyl in post-operative pain
control.
Bangledeshi's Beximco Pharmaceuticals has announced that the
company has raised $21 million after it successfully completed an
institutional placing of global depositary receipts (GDRs).
Dendritic Nanotechnologies (DNT) has signed a collaboration
agreement with Nanotechnology Characterisation Laboratory (NCL),
which is focused on the discovery and development of dendrimer
technologies.
Dynatek dalta Scientific Instruments are to introduce its
drug-eluting stent tester to audiences throughout the US and
Europe, signifying the first time a coating durability tester for
medical devices has been commercially available.
The pharmaceutical division of French packaging company Valois has
completed construction of a pilot filling and packaging unit based
at its site in Le Vaudreuil in the Eure area of France, dedicated
to the production of pressurised...
Australian drug delivery company pSivida has inked a deal valued at
$104 million (€87m) to buy Control Delivery Systems of the US,
allowing it tap into the biotechnology hub around Boston on the US
east coast.
Researchers in France have developed a new microporous material
that could have a range of applications for the pharmaceutical
industry, including chemical separation and catalysis in medicine
manufacturing and drug delivery.
UK drug delivery company Skyepharma has been forced to raise funds
to carry out trials of its combination drug for asthma and chronic
obstructive pulmonary disease (COPD) after failing to find a
partner for the project.
Danish pharmaceutical company Novo Nordisk has filed a lawsuit
against France's Sanofi-Aventis, alleging that the latter has
infringed patent protection for an insulin injection system for
diabetes patients.
Foamix, an Israeli company specialising in the development of
topical drug delivery systems, has entered into an agreement with
drugmaker Stiefel Laboratories for the development of a foam-based
treatment for scabies.
UK microencapsulation specialist Micap has seen the departure of
both chief executive Michael Brennand and non-executive chairman
Ian Gowrie Smith in a bid to cut the executive payroll.
French drug delivery company Novagali Pharma has completed
early-stage clinical testing of an oral formulation of paclitaxel,
a widely used cancer drug usually delivered by intravenous
infusion.
Germany's Merck KGaA has laid out its plans to take on the market
for generic respiratory medicines, revealing that it is the
previously unnamed company that has licensed UK inhaler company
Innovata's Clickhaler device in...
Applied Pharma Research, a Swiss R&D firm specialising in drug
delivery, has granted an exclusive license to US drugmaker ProEthic
Pharmaceuticals to develop and market two fast-acting formulations
of the painkiller diclofenac...
BioSante Pharmaceuticals has licensed its calcium phosphate (CaP)
nanotechnology - used for drug delivery and as an adjuvant for
vaccines - to an unnamed European pharmaceutical company.
Sugar is a useful excipient for use in medications because of its
ability to mask bitter tastes, but its use in drugs intended for
chronic use, or which reside in the mouth for an extended period,
raises the risk of dental caries.
A novel painkiller in development at Pain Therapeutics - based on a
technology that both improves dosing and prevents drug abuse - has
done well in a Phase III clinical trial.
Diabetics moved a step closer to having an alternative to
injections for their insulin therapy yesterday, after a US Food and
Drug Administration (FDA) advisory committee gave its backing to an
inhaled formulation of the drug developed...
A clinical trial will shortly get underway to see if insulin,
delivered intranasally using an atomiser developed by Kurve
Technology, can improve short-term memory in Alzheimer's disease
patients.
MonoSolRx is planning to develop controlled drugs such as opioid
analgesics in its dissolving films, an emerging dosage format for
the oral delivery of drugs and nutritonal products.
Scientists in the US have been using DNA buckyballs as a nanoscale
building material, constructing geometric shapes and even working
mechanical devices with the hope of developing this technology for
drug delivery, using synthetic...
Nektar Therapeutics is planning to buy fellow drug delivery
specialist Aerogen for $32 million (€26m), boosting its position in
respiratory technologies.
Viatris, a German pharmaceutical company specialising in inhaled
medicines and other specialty drugs, has accepted a €750 million
takeover offer from Swedish drugs group Meda.
A team of materials scientists and biologists in the US say they
have developed 'smart' bio-nanotubes that could be used to deliver
a drug or gene to a particular location in the body.
Aegis Therapeutics announced it has entered into a licensing agreement for its patented Intravail drug delivery technology for application to several paediatric therapeutics.
MAP Pharmaceuticals has broadened its agreement with Elan Corp to
develop improved formulations of respiratory drugs to include
combination asthma treatments and inhaled drugs for other lung
diseases.
Scientists have developed a nanoparticle that can penetrate a
tumour, cut off its blood supply and release a lethal dose of
anti-cancer toxins, while leaving healthy cells unscathed.
UK company Diurnal has received orphan product designation from the
European Commission for a novel treatment that uses a drug delivery
technology to match the body's circadian rhythms.
UCLA chemists have created the first nano valve that can be opened
and closed at will to trap and release molecules. The nano valve
could potentially be used as a drug delivery system, trapping and
releasing therapeutic molecules...
US pharmaceutical company Upsher-Smith Laboratories has been forced
into staffing cuts and a restructuring exercise by delays in the US
Food and Drug Administration's review of its nasal calcitonin
product for osteoporosis.
Merrion Pharmaceuticals has been granted a US patent for a drug
delivery technology that improves the transport of medicines across
biological membranes.
UK biotechnology company Ionix Pharmaceuticals is gearing up for
acquisition by Vernalis in a share-based deal valuing Ionix at
around £12.5 million (€18.2m).
NMT Medical announced that the company has received approvals to
initiate studies designed to evaluate its new closure technology.
The collagen matrix used in the technology has the potential to
deliver and localise drugs and other...
Israeli drug delivery firm Foamix has been awarded a US patent for
its OilGel technology, a semisolid matrix which turns into a liquid
when rubbed onto the skin and can be used to deliver a broad range
of therapeutic compounds.
UK-headquartered pharma giant GlaxoSmithKline says it has overcome
the manufacturing problems that caused it to voluntarily withdraw
its antidepressant Paxil CR (paroxetine) and diabetes drug
Avandamet (metformin and rosiglitazone)...
Israeli drug company Intec Pharma has published a results of a
clinical trial showing that its drug delivery platform can extend
the release of an active ingredient in the upper gastrointestinal
tract for more than six hours and double...
Australian drug delivery company Acrux, which specialises in
administering medicines through the skin, has reported clinical
results of a contraceptive for women in the form of a spray,
reports Phil Taylor.
UK pharmaceutical company ML Laboratories has acquired Quadrant
Technologies, a company specialising in drug formulation and
stabilisation, for £46.7 million (€70m), boosting its capabilities
in the development of inhaled medicines,...
Germany glassware company Gerresheimer has opened a cleanroom
production facility at its Polish subsidiary Polfa, aimed at the
production of pharmaceutical vials.
The founder, chairman and chief executive of French drug delivery
company Flamel Technologies has been lambasted by disgruntled
shareholders who want to bring in a new management team, writes
Phil Taylor.
An inhaled formulation of the widely-used immunosuppressant drug
cyclosporine has been deemed safe by a US Food and Drug
Administration advisory committee, but the jury is still out over
the efficacy of the treatment, reports Phil...
Novagali Pharma, a biopharmaceutical company developing innovative
drug delivery systems, has started a Phase I clinical trial in
patients with advanced cancer for its oral formulation of the
cancer drug paclitaxel.
The European Union is to part-finance the creation of a European
Theoretical Spectroscopy Facility (ETSF) to advance collaboration
across the continent in the field of nanotechnology, reports
Phil Taylor.
Drug delivery specialist SCOLR Pharma has started pilot testing in
Canada of a formulation of the osteoporosis drug raloxifene that
promises to improve the absorption of the drug and, potentially,
hike its efficacy, reports Phil Taylor.
A delivery technology that could allow vaccines to be administered
intranasally and does not require refrigeration has passed its
first clinical hurdle, reports Phil Taylor.
An antifungal product in development at France's BioAlliance Pharma
has been shown to treat a yeast infection in the mouth with similar
efficacy but 10 times less drug than its nearest competitor,
reports Phil Taylor.
BioProgress has appointed Richard Trevillion as chief
executive, bolstering its executive management just over a month
after the dosage film specialist issued a trading statement that
sparked a 40 per cent slump in its UK-listed shares,...
A single injection could replace implants for some drugs that
require continuous administration, according to preliminary
experiments with a novel drug delivery technology, reports Phil
Taylor.
Engineers in the US have found a way to modify a plastic so that it
can anchor molecules that promote nerve regeneration, blood vessel
growth or other biological processes.
Crosslinking is a natural phenomenon occurring in gelatin that negatively impacts soft capsules, reducing their stability and prolonging their dissolution...
New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...
Invivo: Many orally dosed APIs are bioavailable only when formulated as an enteric dosage form to protect them from the harsh environment of the stomach....